ABOUT this BLOG and How to use it

WELCOME to Stu's Views & MS News. A product of MS Views and News, a Not-for-Profit [501c3] organization. Founded in 2008, we provide educational Multiple Sclerosis information via live seminars and via the internet.

Key-Notes: Our live seminars average approx 60 people per educational program. Our blog is visited over 2900 times per week and our website is visited by thousands each month.

Register at our website to receive our globally transmitted Multiple Sclerosis e-newsletter, currently being received in (90) Countries.

On this blog see our Directory, Archives, recent Blog Posts & so much more. Use the Blog Search box (enter a keyword). See our Facebook information AND Links to other MS Organizations & bloggers. Scroll through entire page, to find information that could EMPOWER You. At the Bottom of this page, see informational videos and some for fun.

Disclaimer: "Stu's Views & MS News" / 'MS Views and News' does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Like this blog? - CLICK "LIKE"

Saturday, October 16, 2010

CCSVI News: Zamboni warns more tests are needed


October 16, 2010



MS new treatment?
Photo: Mike Szymanski
Dr. Paolo Zamboni, who came up with a seemingly simple solution to stopping Multiple Sclerosis, is now urging caution until more clinical trials are done.
This procedure, which he developed in Italy at the University of Ferrera, showed that the improper drainage of blood from the brain may play a part in causing MS. That means treatment of the disease could be by simply opening up the blood vessels to the brain – a procedure called “liberation therapy.”
Dr. Zamboni told an MS conference in Gothenburg, Sweden, that patients shouldn’t go ahead with such surgery, except in the case of clinical trials.
“Surgery is not recommended at this stage,” he said, during a presentation this week to the Congress of the European Committee for Treatment and Research in MS, according to the Globe & Mail. He also said he does not support “medical tourism” – the practice of some patients who travel overseas to clinics that will perform the surgery. Thousands of people are believed to have done this.
The story created strong reactions both pro and con to Zamboni and his treatments: Read comments here.
   

***********************************************************
Keep Informed and up-to-date with information concerning
 Multiple Sclerosis when registered at
****************************************************************
Disclaimer:  'MS Views and News' (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
****************************************************************

1 comments:

Cherie said...

I can't be sure, with the wording of this article, if Dr. Zamboni is trying to cover his tail or stem the tide of patients coming across the water for liberation therapy.

The purpose of this article seems to me to be a generation of interest in and support of the liberation therapy being clinically trialed in Canada. There is really no new information here.